Centene Corporation reaffirmed its full-year 2026 earnings per share (EPS) guidance, confirming GAAP diluted EPS is expected to be greater than $3.11. This figure significantly exceeds the analyst estimate of $2.47.

Management confirmed the targets on September 16, 2026, at 9:00 a.m. EDT. Discussions with investors continued through the week of September 21.

Guidance Details

The company reiterated its specific financial targets for the fiscal year:

These figures represent the company's expected performance for the entire year, excluding any non-recurring items in the adjusted metric.

Centene Corporation (NYSE: CNC) announced a planned leadership transition in its finance function, with outgoing Chief Financial Officer Drew Asher set to step down on December 31, 2026, before retiring from the company at the end of 2027. Chris Neczypor will succeed him, assuming the role of Executive Vice President and Chief Financial Officer on January 1, 2027.

Mr. Neczypor will join Centene in September 2026 to work alongside Mr. Asher during the transition period. Mr. Asher will remain with the organization until his retirement to support strategic initiatives and ensure continuity.

Incoming CFO Background

Mr. Neczypor brings extensive experience in corporate finance, strategy, and capital management. Prior to joining Centene, he served as Executive Vice President and Chief Financial Officer for Lincoln Financial, a provider of life insurance, annuities, group benefits, and retirement solutions. He joined Lincoln in 2018, holding various leadership positions including Chief Strategy Officer, with responsibilities spanning investments, strategic planning, and enterprise transformation.

Before his tenure at Lincoln Financial, Mr. Neczypor spent more than a decade in investment and financial services roles. His background includes serving as an equity research analyst at Goldman Sachs and as an investor at institutional asset management firms.

Outgoing CFO Tenure

Mr. Asher has served as Centene’s CFO since 2021. During his tenure, the company expanded significantly in scale. Revenue grew from approximately $126 billion in 2021 to approximately $195 billion in 2025, reflecting substantial growth amid broader transformation across the healthcare industry.

Sarah M. London, Chief Executive Officer, highlighted Mr. Neczypor’s track record in strengthening financial performance and optimizing operations. "Chris brings a proven track record of strengthening financial performance, optimizing operations and creating long-term shareholder value," Ms. London said. "Our organization will benefit from his expertise, energy and perspective as we deliver on Centene's next phase of transformation and growth."

Mr. Asher expressed confidence in the company’s future direction. "The foundation we've built and the outstanding team we've assembled give me confidence in Centene's ability to transform healthcare and provide value for shareholders," he said.

What the Numbers Show

The revenue growth cited during Mr. Asher’s tenure underscores the scale of operations the incoming CFO will manage. Centene’s revenue increased by approximately $69 billion over the four-year period from 2021 to 2025, rising from $126 billion to $195 billion. This expansion occurred while the company navigated significant changes in the healthcare sector.

Guidance Reaffirmation

Centene reaffirmed its previously issued full-year 2026 guidance metrics. The company maintained its target for adjusted diluted earnings per share (EPS) of greater than $4.80 for the full year 2026. These figures align with the guidance provided in its July 28, 2026, second-quarter earnings press release.

Centene Corporation is a Fortune 500 healthcare enterprise focused on providing integrated services to government-sponsored and commercial healthcare programs. The company serves more than one in 15 individuals across the nation, including Medicaid and Medicare members.